The CX3C Chemokine Fractalkine (CX3CL1) Is Detectable in Serum of B Cell Chronic Lymphocytic Leukemia Patients with Lymph Node Involvement

Publisher： Karger

E-ISSN： 1421-9662|113|2|152-154

ISSN： 0001-5792

Source： Acta Haematologica, Vol.113, Iss.2, 2005-03, pp. : 152-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Modulation of platelet and monocyte function by the chemokine fractalkine (CX3CL1) in cardiovascular disease

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 6, 2015-06 ,pp. : 624-633

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rôle de la fractalkine/CX3CL1 et de son récepteur CX3CR1 dans les pathologies allergiques

By Julia Valérie   Staumont-Salle Delphine   Dombrowicz David  

Médecine/sciences, Vol. 32, Iss. 3, 2016-03 ,pp. : 260-266

Edp Sciences

Access to resources Recommend Favorite

Heparin Inhibits IFN-γ-Induced Fractalkine/CX3CL1 Expression in Human Endothelial Cells

By Hatakeyama Masaharu   Imaizumi Tadaatsu   Tamo Wakako   Yamashita Koji   Yoshida Hidemi   Fukuda Ikuo   Satoh Kei  

Inflammation, Vol. 28, Iss. 1, 2004-02 ,pp. : 7-13

Springer Publishing Company

Access to resources Recommend Favorite

Common polymorphisms of chemokine (C‐X3‐C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population‐based study

By  

MUSCLE AND NERVE, Vol. 57, Iss. 2, 2018-02 ,pp. : 212-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors

By Nassar B. A.   Nanji A. A.   Ransom T. P.   Rockwood K.   Kirkland S. A.   MacPherson K.   Connelly P. W.   Johnstone D. E.   O'Neill B. J.   Bata I. R.   Andreou P.   Title L. M.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 4, 2008-07 ,pp. : 286-291

Informa Healthcare

Access to resources Recommend Favorite